Rocket Lab's September Reckoning: A $1.94 Billion Bet Hangs on One Vote

Rocket Lab's backlog tops $2.36B, but stock dips 9% as Iridium shareholder vote on Sept. 24 nears.

The gap between what Rocket Lab is achieving and what its share price is saying has rarely been wider. Over the past two weeks, the company has launched satellites, won government contracts, and pushed its backlog past the $2 billion mark — yet the stock closed at €56.90 after shedding 9.0 percent in a single week. That disconnect is now converging on a single date: September 24, when Iridium Communications shareholders vote on the proposed acquisition that would transform Rocket Lab from launch provider into owner of a global satellite network.

The Mechanics of a Pending Deal

The procedural machinery is already in motion. The waiting period under US antitrust law expired on August 12, Rocket Lab has filed its S-4 registration with the SEC, and both companies have petitioned the FCC to transfer Iridium's licenses. None of these steps constitute a done deal — the shareholder vote remains the true gatekeeper.

What has added a layer of complexity is a new at-the-market equity program worth up to roughly $1.94 billion, arranged through Deutsche Bank Securities and Wells Fargo Securities. It replaces an earlier May program and absorbs its unplaced volume. For existing Rocket Lab shareholders, the question is straightforward: how much dilution will this program actually deliver? The answer depends on the share price trajectory and how much capital the Iridium transaction ultimately requires.

A Backlog That Commands Attention

Set against that uncertainty is an operating business firing on multiple cylinders. The August 20 launch marked the 93rd Electron mission and the 14th of 2026, successfully deploying an iQPS Earth-observation satellite. Rocket Lab has also confirmed nine additional firm iQPS launches through 2030 — a revenue cushion that stands independent of the Iridium outcome.

The government pipeline is equally robust. Eight of 17 satellite platforms built under the $143 million MDA Space contract for Globalstar reached orbit on August 15. The company has been admitted to the Space Data Network Consortium of the US Space Force with two delivery orders totaling $12 million for optical communications testing on the Photon platform. Viasat has selected Rocket Lab to build a satellite bus on the Lightning-GEO platform for a Space Force program, and the company has been included in the NITE-STAR framework agreement with a program volume of up to $981 million.

This density of government work helps explain why Seeking Alpha upgraded the stock to "Buy" on August 22, citing a backlog that has grown to $2.36 billion — up 137 percent year over year — alongside a more comfortable margin of safety after the recent pullback.

Insider Sales With a Caveat

The picture is complicated by a cluster of insider transactions reported on August 24. Chief Operating Officer Frank Klein sold 45,692 shares worth roughly $3.18 million, President Marvin Bradford Clevenger disposed of 15,051 shares for about $1.05 million, CFO Adam C. Spice sold 9,677 shares, and Senior Vice President Arjun Kampani offloaded 7,754 shares.

The crucial detail is the nature of these trades: all were "sell-to-cover" transactions to settle tax liabilities from vesting restricted stock units. That is routine mechanics, not a signal of fading management conviction — though the timing does little to calm a market already wrestling with divergent analyst opinions.

Wall Street Zen downgraded the stock from "Hold" to "Sell" on August 15, pointing to a wider-than-expected adjusted loss of $0.08 per share in the latest quarter and elevated valuation multiples. The same day, Pluang raised its price target to $209 with a "Buy" rating, citing record revenue of $234.1 million in the second quarter and faster-than-expected expansion of vertically integrated infrastructure. The chasm between those two views captures the core debate: growth versus profitability, and at what price.

The Neutron Variable

Beyond Iridium, the development of the Neutron rocket remains an open factor. Reports from August 24 indicate Rocket Lab is working on a reusable fairing technology dubbed "Hungry Hippo" and targeting delivery to the launch pad in the fourth quarter of 2026, while tests on heat shielding, control surfaces, avionics, and fluid systems are still underway. That is a development milestone, not a confirmed launch date. Any further delay would weaken the growth narrative — particularly for investors who view the Iridium deal partly as diversification away from an unproven rocket.

What the Chart Says Now

Technically, the stock sits roughly 18 percent below its 50-day moving average, with an RSI of 35.3 suggesting oversold conditions. The current price of €56.90 compares with a 50-day average of €68.57, a discount of about 17 percent. The market is clearly pricing in uncertainty rather than celebration.

The next concrete checkpoint after the September 24 vote is the FCC's decision on the license transfer, followed by third-quarter earnings on November 9. Management has guided to revenue between $250 million and $265 million for the quarter — a figure that will test whether operational momentum translates into sustainable growth or whether the skeptics have it right.

For now, Rocket Lab is a bet on two parallel processes: the integration of a satellite network and the maturation of a new rocket. Both remain unresolved, and the September vote is the first moment of truth.